Skip to Content

Etomidate Injection

Last Updated: March 31, 2018
Status: Current

etomidate Injection

Products Affected - Description
  • Amidate injection, Pfizer

2 mg/mL, 20 mL LifeShield syringe, 10 count (NDC 00409-8060-29)
2 mg/mL, 20 mL vial, 10 count (NDC 00409-6695-02)
 
Etomidate injection, American Regent
2 mg/mL, 10 mL vial, 10 count (NDC 00517-0780-10)
2 mg/mL, 20 mL vial, 10 count (NDC 00517-0781-10)
 
Etomidate injection, AuroMedics
2 mg/mL, 10 mL vial, 10 count (NDC 55150-0221-10)
 
Etomidate injection, Mylan Institutional
2 mg/mL, 10 mL vial, 10 count (NDC 67457-0477-10)
2 mg/mL, 20 mL vial, 10 count (NDC 67457-0456-21)
 
Etomidate injection, West-Ward
2 mg/mL, 10 mL vial, 10 count (NDC 00143-9506-10)
 
Etomidate injection, Zydus
2 mg/mL, 20 mL vial, 10 count (NDC 68382-0545-08)
Reason for the Shortage
    • American Regent did not provide a reason for the current shortage.
    • AuroMedics did not provide a reason for the current shortage.
    • Mylan did not provide a reason for the current shortage.
    • Par Sterile Products discontinued etomidate in early 2015.
    • Pfizer has Amidate on shortage due to manufacturing delays. Pfizer discontinued etomidate ampules in October 2016.
    • Sagent is no longer marketing etomidate.
    • West-Ward did not provide a reason for the current shortage.
    • Zydus had etomidate on shortage due to an increase in demand.
Available Products
  • Amidate injection, Pfizer
    2 mg/mL, 10 mL vial, 10 count (NDC 00409-6695-01)

 
Etomidate injection, Athenex
2 mg/mL, 10 mL vial, 10 count (NDC 70860-0652-10)
2 mg/mL, 20 mL vial, 10 count (NDC 70860-0652-20)
 
Etomidate injection, AuroMedics
2 mg/mL, 20 mL vial, 10 count (NDC 55150-0222-20)
 
Etomidate injection, West-Ward
2 mg/mL, 10 mL vial, 10 count (NDC 00143-9506-10)
2 mg/mL, 20 mL vial, 10 count (NDC 00143-9507-10)

Etomidate injection, Zydus
2 mg/mL, 10 mL vial, 10 count (NDC 68382-0545-07)

Estimated Resupply Dates

    • American Regent has etomidate 2 mg/mL 10 mL and 20 mL vials on back order and the company cannot estimate a release date.
    • AuroMedics has 2 mg/mL 10 mL vials on intermittent back order.
    • Mylan Institutional has etomidate 2 mg/mL 10 mL and 20 mL vials on back order and the company estimates a release date of early-August 2018.
    • Pfizer has Amidate 2 mg/mL 20 mL LifeShield syringes on back order and the company cannot estimate a release date. The 2 mg/mL 20 mL vials are available in limited supply.
    • Zydus has etomidate 2 mg/mL 20 mL vials on intermittent back order.

Safety

  • Clinicians must take extra care to ensure safe use of etomidate when using different presentations than those normally stocked.

Updated

March 31 and 14 and 7, February 6 and 5, January 24 and 6, 2018; December 12, September 30, August 30 and 15, July 31 and 10, May 5, March 21, 14 and 7, February 21, 2017; December 19 and 14, November 1, September 27, August 25, June 2, January 29, 2016; December 11, November 30, October 29, September 4, August 24 and 13, July 15, April 28, 17 and 16, March 23 and 2, February 12, 2015; December 22 and 18, October 3, September 17 and 5, August 7 and 1, July 15 and 8, May 16, March 31 and 20, February 27 and 21, January 24, 2014; December 12 and 6, October 24 and 9, September 3, February 25 and 13, January 31, 29, 22 and 11, 2013; December 14 and 7, November 19 and 5, October 4, September 14, August 7, February 27, 14 and 7, January 31, 27 and 4, 2012; December 19 and 6, October 26, August 31 and 3, July 6, 2011, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide